Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/TargED Biopharmaceutical

TargED Biopharmaceutical

Series A
Utrecht, NetherlandsFeb 2022
Healthtech

TargED Biopharmaceutical raised €39M in a Series A round in Feb 2022. The company is based in Utrecht, Netherlands. Investors in the round: Andera Partners, Curie Capital, FIRST Fund and 5 others. Data as of Nov 2026.

← TargED Biopharmaceutical
Amount raised
€39M
€39,000,000
Native amount
39,000,000 EUR
Stage
Series A
series a
Investors
8

Provenance & confidence

High confidence
Amount

Reported in EUR — no conversion. €39M

High confidence
Source

finsmes.com · established

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

8 named
Andera PartnersCurie CapitalFIRST FundFundPlusHadean VenturesINKEF CapitalSunstone Life Science VenturesUtrecht Health Seed Fund
Date
Feb 2022
Round type
series a
Amount (EUR)
€39M

Other rounds

same company

This is the company's only recorded round.

Related news